ENZYME-LINKED-IMMUNOSORBENT-ASSAY OF HUMAN FACTOR-VII BASED UPON A MONOCLONAL-ANTIBODY THAT RECOGNIZES THE NATIVE CONFORMATION OF THE PROTEIN

被引:19
作者
COPPOLA, R
TOMBESI, S
VALENTINI, F
ALBORALI, S
ALBERTINI, A
MANNUCCI, PM
机构
[1] MAGGIORE HOSP & UNIV,IRCCS,ANGELO BIANCHI BONOMI HEMOPHILIA & THROMBOSIS CTR,MILAN,ITALY
[2] MAGGIORE HOSP & UNIV,IRCCS,INST INTERNAL MED,MILAN,ITALY
[3] UNIV BRESCIA,SCH MED,INST CHEM,BRESCIA,ITALY
关键词
FACTOR-VII; ANTICOAGULANT THERAPY; LIVER DISEASE; PREGNANCY; MYOCARDIAL INFARCTION;
D O I
10.1016/0049-3848(92)90085-O
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
An enzyme-linked immunoassay (ELISA) was developed for measuring human factor VII antigen using two monoclonal antibodies, one of them reacting only with fully carboxylated factor VII. This assay permits to measure factor VII antigen in concentrations ranging from 0.78 to 100 ng/ml, with within- and between-assay coefficients of variation of less then 7%.In 53 normal subjects, 32 patients with liver cirrhosis, 21 pregnant women and 53 patients on oral anticoagulant therapy the plasma levels of FVII antigen were very similar to those of factor VII coagulant activity measured with a bioassay. The ELISA also gave very similar values of factor VII antigen in plasma and in serum, and in plasma before and after exposure to cold, indicating that the assay is not affected by factor VII activation. In five of 8 patients with severe congenital deficiency of factor VII values of factor VII antigen were higher than those of factor VII activity. The close concordance of factor VII values obtained by ELISA and bioassay in the majority of plasmas, including those from patients on oral anticoagulant therapy, indicates that the assay measures native factor VII and can perhaps replace the bioassay sistems in clinical conditions associated with normal or high levels of factor VII.
引用
收藏
页码:283 / 293
页数:11
相关论文
共 15 条
[1]  
BIGGS R, 1972, HUMAN BLOOD COAGULAT, P629
[2]  
BOYER C, 1986, THROMB HAEMOSTASIS, V56, P250
[3]   CHARACTERIZATION AND COMPARISON OF IMMUNE-DEPLETED AND HEREDITARY FACTOR-VII-DEFICIENT PLASMAS AS SUBSTRATE PLASMAS FOR FACTOR-VII ASSAYS [J].
BRANDT, JT ;
TRIPLETT, DA ;
FAIR, DS .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1986, 85 (05) :583-589
[4]   MONOCLONAL ANTI-HUMAN FACTOR-VII ANTIBODIES - DETECTION IN PLASMA OF 2ND PROTEIN ANTIGENICALLY AND GENETICALLY RELATED TO FACTOR-VII [J].
BROZE, GJ ;
HICKMAN, S ;
MILETICH, JP .
JOURNAL OF CLINICAL INVESTIGATION, 1985, 76 (03) :937-946
[5]  
COPPOLA R, CHARACTERIZATION CA
[6]  
FAIR DS, 1983, BLOOD, V62, P784
[7]   COLD PROMOTED ACTIVATION OF FACTOR-VII .4. RELATION TO COAGULATION SYSTEM [J].
GJONNAESS, H .
THROMBOSIS ET DIATHESIS HAEMORRHAGICA, 1972, 28 (02) :194-+
[8]  
GOODNIGHT SH, 1971, BLOOD-J HEMATOL, V38, P1
[9]  
HOFFMAN C, 1988, J LAB CLIN MED, V111, P475
[10]  
LOWE GDO, 1991, THROMB HAEMOSTASIS, V65, P339